Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
CRCronos Group Inc. logo

Cronos Group Inc. (CRON)

NASDAQ Global Market · Currency in USD
$3.31 ▼ -0.04 (-1.19%)
At close: Oct 26, 4:00 PM ET. Market closed.
$3.29 ▼ -0.02 (-0.60%)
After hours: Oct 26, 7:54 PM ET

Summary

Previous Close
$3.35
Open
$3.37
Day's Range
$3.29 – $3.41
52 Week Range
$2.28 – $3.61
Volume
820,275
Avg. Volume
1,067,678
Market Cap
$1.22B
Beta (5Y Monthly)
1.20
PE Ratio (TTM)
17.71
EPS (TTM)
$0.19
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$3.15

Profile: Cronos Group Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
610
CEO
Michael Ryan Gorenstein

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $0.03 · Revenue est. $51.15M
DateEst.Actual
Aug 6, 2026$0.01$0.09Beat
May 11, 2026$0.01$0.04Beat
Feb 26, 2026$0.01-$0.00Miss
Nov 6, 2025$0.02$0.07Beat
Aug 7, 2025-$0.02-$0.10Miss
May 8, 2025$0.01$0.02Beat

Analyst view

Consensus price target
$3.15 ▼ -4.8%
Range $2.30 – $4.50
Rating: Hold
Buy 20% · Hold 60% · Sell 20%

Get free alerts on CRON and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.